Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.nature.com/articles/1001808.pdf
Reference89 articles.
1. HE J, Whelton PK . Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized control trials. Am Heart J 1999; 138(Suppl 3): S211–S219.
2. Klag MJ et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13–18.
3. MacMahon S et al. Blood pressure, stroke and coronary heart disease: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.
4. He J et al. Risk factors for congestive heart failure in US men and women. NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161: 996–1002.
5. Kannel WB . Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA 1996; 275: 1571–1576.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison on Safety and Efficacy of Telmisartan and Losartan with their Effects on Cardiovascular – A Single Centre Study;Journal of Pharmaceutical Research International;2021-04-14
2. The Efficiency of Telmisartan in Hypertension Management as a Monotherapy or Combined; Literature Review;Archives Of Pharmacy Practice;2021
3. Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments;Journal of Clinical Pharmacy and Therapeutics;2018-06-16
4. Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study;Hypertension Research;2016-10-20
5. Telmisartan Exerts Sustained Blood Pressure Control and Reduces Blood Pressure Variability in Metabolic Syndrome by Inhibiting Sympathetic Activity;American Journal of Hypertension;2014-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3